Scalper1 News
Medical-product maker Baxter International (BAX) beat analysts’ Q2 expectations Thursday, but its conservative guidance underwhelmed the Street. Shares dropped early but recovered and was flat in midday trading in the stock market today. Baxter’s Q2 earnings rose 5% over the year-earlier quarter to $1.26 a share, topping analysts’ consensus by 4 cents. Sales rose 16% to $4.3 billion, beating analysts’ $4.1 billion. Baxter narrowed its full-year Scalper1 News
Scalper1 News